Veratramine

Catalog No.S3911 Batch:S391101

Print

Technical Data

Formula

C27H39NO2
Molecular Weight 409.60 CAS No. 60-70-8
Solubility (25°C)* In vitro DMSO 63 mg/mL (153.8 mM)
 
 
In vivo (Add solvents to the product individually and in order)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Veratramine (NSC 17821, NSC 23880), a major alkaloid from Veratrum nigrum L., has distinct anti-tumor and anti-hypertension effects. It is a good membrane permeant, undergoes rapid passive diffusion, and has a good stability in the gastrointestinal tract during its absorption.
In vitro Veratramine antagonizes the Na+ channel-gating mechanism of ceveratrum alkaloids by blocking Na+ channels. Veratramine also shows serotonin (5-HT) agonist activity, acting on presynaptic 5-HT neurons[1].
In vivo The administration of vertatramine induces generalized tremors, myoclonus, hindlimb abduction, backward gait, and Straub tail, similar to the 5-HT syndrome in mice. Veratramine causes bradycardia and periodic rhythm in the sinoatrial node of the guinea pig. The lethal dose 50% (LD50) of VAM for mice is 15.9 mg/kg with intragastrical administration [1]. Vertatramine causes DNA damage in the cerebellum and cerebral cortex of mice in a dose-dependent manner. As a major Veratrum alkaloid, veratramine (VAM) is significantly effective against hypertension by reflective inhibition of vasomotor center and tumor as an antagonist of the hedgehog signaling. Vertatramine may exert neurotoxic effects[2].

Protocol (from reference)

Animal Study:[1]
  • Animal Models

    Kunming mice

  • Dosages

    0.56 to 2.24 mg/kg

  • Administration

    oral ingestion

References

  • https://pubmed.ncbi.nlm.nih.gov/18771011/
  • https://watermark.silverchair.com/bmu171.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAbAwggGsBgkqhkiG9w0BBwagggGdMIIBmQIBADCCAZIGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMSXHtjn_ZivO0uYWqAgEQgIIBY2RxIqsIFVd0APwpkhvA46irFSnwuOwTRD5WPbWNjopRUBZZ_x0018_䲧畘Ỵ留

Selleck's Veratramine has been cited by 1 publication

Veratramine inhibits porcine epidemic diarrhea virus entry through macropinocytosis by suppressing PI3K/Akt pathway [ Virus Res, 2023, 10.1016/j.virusres.2023.199260] PubMed: 37923169

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.